Amrutanjan Health Care Limited

Amrutanjan Health Care Limited (AMRUTANJAN) is a micro-cap Healthcare company valued at ₹1,499 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Amrutanjan Health Care Limited last traded at ₹514.3, modestly up 1.64% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing a significant drop in net profit. Promoter holding remained at 46.52%, while foreign institutional holding increased by 0.27 percentage points and domestic institutional holding decreased by 0.38 percentage points.

Financial performance

The company's annual revenue rose 11.2% to ₹503 crore, while annual net profit increased 13.6% to ₹58 crore. However, the latest quarter showed a sharp decline in net profit, which fell 47.4% to ₹4 crore, despite revenue rising 9.5% to ₹103 crore compared to the same quarter a year earlier.

Valuation multiples

The stock trades at 25.7 times earnings, a discount to the Healthcare median of 32.0, 3.86 times book value. It yields 1.0%.

Things to watch

The latest quarter net profit fell 47.4%, which is a major concern. The stock is 32.5% below its 52-week high, and the 5-year profit CAGR is negative at -1.0%.

Where it stands

The company has shown steady revenue growth over the past five years, but recent quarterly results highlight a significant drop in profitability. The stock is trading at a discount to its 52-week high, and the latest quarter's net profit decline is the most notable fact.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.